NUTRIM aims to contribute to health maintenance and personalised medicine by unraveling lifestyle and disease-induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions.
This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.
NUTRIM research focuses on chronic diseases, including diabetes, COPD, inflammatory bowel disease, liver disease and renal disease, and contributes to improving cancer care. Biomedical research is directly linked to clinical trials and research focusing on behavioural interventions and health promotion. A primary goal is to accelerate the translation of science to patient and population. This distinct profile has placed NUTRIM at the cutting-edge of various related domains. NUTRIM's research lines are:
NUTRIM offers a PhD training programme for students who aspire a broad understanding of human nutrition, metabolism and toxicology, next to outstanding research capabilities. NUTRIM researchers also teach in several master’s programmes, such as ‘Biomedical Sciences’, ‘Physician Clinical Scientist’ and ‘Health Food Innovation Management’.
"NUTRIM has an internationally leading position in nutritional and metabolic management of Chronic obstructive Pulmonary Disease."
“Diabetes research in the Netherlands is, in comparison to other countries in the world, very competitive.”
“My aim is to understand the mechanisms by which liver inflammation develops and to develop new non-invasive markers to detect inflammation. And, of course, to develop novel treatment options for this disease.”
“NUTRIM’s strength lies in the fact that the patients’ interests are not overlooked and a lot of attention is paid to ‘translational research’.”
A reversal of the day and night rhythm, due to shift work for example, leads to a disturbance in blood sugar levels. Scientists from Maastricht University have demonstrated this for the first time in humans.
NUTRIM researchers Prof. dr. Patrick Schrauwen and Dr Vera Schrauwen-Hinderling have won the Bio Art & Design Award 2018 (BAD Award) together with artist Yiyun Chen.